Renato Marchiori Bakos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Renato Marchiori Bakos has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Clarissa Prieto Herman Reinehr
Postgraduation in Medical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
7 shared publications - Leandro Linhares Leite
Hospital de Clínicas de Porto Alegre, Brazil
6 shared publications - Gabriela Fortes Escobar
Department of Dermatology, Hospital de Clínicas de Porto Alegre, Brazil
5 shared publications - Giuseppe Argenziano
Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine University of Campania Luigi Vanvitelli Naples Italy
4 shared publications - Bianca Costa Soares de Sá
Department of Dermatology, Núcleo de Câncer de Pele, A.C. Camargo Câncer Center, São Paulo, SP, Brazil
3 shared publications - Carlos Baptista Barcaui
Instituto de Dermatologia Prof. Rubem David Azulay, Santa Casa da Misericórdia do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
3 shared publications
Latest Publications
- Open Access
- 8 May 2026
- Published by Wiley in Experimental Dermatology
- Vol. 35 (5) , e70264
A Phase II Trial of Perioperative Oral Itraconazole for the Management of Low‐Risk Basal Cell Carcinoma
Recently, new treatment strategies have been developed for advanced or metastatic basal cell carcinoma (BCC), including Hedgehog pathway inhibitors. Itraconazole has demonstrated clinical activity in such cases by blocking the smoothened (SMO) receptor. Such a strategy could be used in early disease. The objective of this Phase II study was to evaluate the clinical and molecular efficacy of Itraconazole in low‐risk BCC patients who were primarily candidates for surgical excision. Lesions were assessed according to RECIST 1.1 criteria, with target lesions being at least 10 mm in size after confirmatory biopsy. Patients received itraconazole tablets 200 mg twice daily for 60 days before resection. The median tumour diameter before treatment was 14 mm (IQR 11–16 mm), and after treatment, 13 mm (IQR 11–15 mm), and this reduction in tumour size was statistically significant ( p < 0.0001). Coupled with the decrease in tumour size, a decrease in the expression of CD105, an endothelial marker ( p < 0.0001), was observed. In conclusion, neoadjuvant itraconazole for 2 months was able to reduce the diameter of low‐risk BCC, and the effect was associated with a decrease in tumour angiogenesis and a favourable safety profile.
- 8 May 2026
- Published by Wiley in Experimental Dermatology
- Vol. 35 (5) , e70264
Open AccessA Phase II Trial of Perioperative Oral Itraconazole for the Management of Low‐Risk Basal Cell Carcinoma
Recently, new treatment strategies have been developed for advanced or metastatic basal cell carcinoma (BCC), including Hedgehog pathway inhibitors. Itraconazole has demonstrated clinical activity in such cases by blocking the smoothened (SMO) receptor. Such a strategy could be used in early disease. The objective of this Phase II study was to evaluate the clinical and molecular efficacy of Itraconazole in low‐risk BCC patients who were primarily candidates for surgical excision. Lesions were assessed according to RECIST 1.1 criteria, with target lesions being at least 10 mm in size after confirmatory biopsy. Patients received itraconazole tablets 200 mg twice daily for 60 days before resection. The median tumour diameter before treatment was 14 mm (IQR 11–16 mm), and after treatment, 13 mm (IQR 11–15 mm), and this reduction in tumour size was statistically significant ( p < 0.0001). Coupled with the decrease in tumour size, a decrease in the expression of CD105, an endothelial marker ( p < 0.0001), was observed. In conclusion, neoadjuvant itraconazole for 2 months was able to reduce the diameter of low‐risk BCC, and the effect was associated with a decrease in tumour angiogenesis and a favourable safety profile.
- Open Access
- 13 November 2025
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 100 (6)
Achados histológicos e imuno‐histoquímicos em nevos recorrentes
- 13 November 2025
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 100 (6)
Open AccessAchados histológicos e imuno‐histoquímicos em nevos recorrentes
- Open Access
- 12 July 2024
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 191 (5) , 847-848
Prediction of melanoma metastasis using dermatoscopy deep features: an international multicentre cohort study
Whether dermatoscopy deep features could serve as biomarker for the prediction of melanoma metastasis remains an underexplored area in medical research. In this cohort of 712 patients from 10 centres in 3 continents, a support vector machine classifier that analysed deep features on dermatoscopic images demonstrated similar prognostic performance for metastasis in terms of AUC and true positive rate to current benchmarks of melanoma staging, namely Breslow thickness and ulceration. Deep features derived from dermatoscopy could predict early-stage melanomas with high metastatic potential, tailoring further treatment strategies.
- 12 July 2024
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 191 (5) , 847-848
Open AccessPrediction of melanoma metastasis using dermatoscopy deep features: an international multicentre cohort study
Whether dermatoscopy deep features could serve as biomarker for the prediction of melanoma metastasis remains an underexplored area in medical research. In this cohort of 712 patients from 10 centres in 3 continents, a support vector machine classifier that analysed deep features on dermatoscopic images demonstrated similar prognostic performance for metastasis in terms of AUC and true positive rate to current benchmarks of melanoma staging, namely Breslow thickness and ulceration. Deep features derived from dermatoscopy could predict early-stage melanomas with high metastatic potential, tailoring further treatment strategies.
- Open Access
- 1 October 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (4) , e2022182
Indications for Digital Monitoring of Patients With Multiple Nevi: Recommendations from the International Dermoscopy Society
Introduction: In patients with multiple nevi, sequential imaging using total body skin photography (TBSP) coupled with digital dermoscopy (DD) documentation reduces unnecessary excisions and improves the early detection of melanoma. Correct patient selection is essential for optimizing the efficacy of this diagnostic approach. Objectives: The purpose of the study was to identify, via expert consensus, the best indications for TBSP and DD follow-up. Methods: This study was performed on behalf of the International Dermoscopy Society (IDS). We attained consensus by using an e-Delphi methodology. The panel of participants included international experts in dermoscopy. In each Delphi round, experts were asked to select from a list of indications for TBSP and DD. Results: Expert consensus was attained after 3 rounds of Delphi. Participants considered a total nevus count of 60 or more nevi or the presence of a CDKN2A mutation sufficient to refer the patient for digital monitoring. Patients with more than 40 nevi were only considered an indication in case of personal history of melanoma or red hair and/or a MC1R mutation or history of organ transplantation. Conclusions: Our recommendations support clinicians in choosing appropriate follow-up regimens for patients with multiple nevi and in applying the time-consuming procedure of sequential imaging more efficiently. Further studies and real-life data are needed to confirm the usefulness of this list of indications in clinical practice.
- 1 October 2022
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 12 (4) , e2022182
Open AccessIndications for Digital Monitoring of Patients With Multiple Nevi: Recommendations from the International Dermoscopy Society
Introduction: In patients with multiple nevi, sequential imaging using total body skin photography (TBSP) coupled with digital dermoscopy (DD) documentation reduces unnecessary excisions and improves the early detection of melanoma. Correct patient selection is essential for optimizing the efficacy of this diagnostic approach. Objectives: The purpose of the study was to identify, via expert consensus, the best indications for TBSP and DD follow-up. Methods: This study was performed on behalf of the International Dermoscopy Society (IDS). We attained consensus by using an e-Delphi methodology. The panel of participants included international experts in dermoscopy. In each Delphi round, experts were asked to select from a list of indications for TBSP and DD. Results: Expert consensus was attained after 3 rounds of Delphi. Participants considered a total nevus count of 60 or more nevi or the presence of a CDKN2A mutation sufficient to refer the patient for digital monitoring. Patients with more than 40 nevi were only considered an indication in case of personal history of melanoma or red hair and/or a MC1R mutation or history of organ transplantation. Conclusions: Our recommendations support clinicians in choosing appropriate follow-up regimens for patients with multiple nevi and in applying the time-consuming procedure of sequential imaging more efficiently. Further studies and real-life data are needed to confirm the usefulness of this list of indications in clinical practice.
- 27 December 2021
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 48 (3) , 299-303
Dermoscopic Aspects of Traumatized Nevi After Dermabrasion
BACKGROUND: Melanocytic nevi submitted to trauma can undergo clinical, dermoscopic, and even histological changes, making it difficult to differentiate them from a melanoma. OBJECTIVE: The aim of this study is to evaluate the dermoscopic changes of traumatized nevi after dermabrasion. METHODS: Dermoscopic images of acquired melanocytic nevi were compared before and 4 weeks after half of their area had undergone dermabrasion. RESULTS: The sample consisted of 50 lesions from 15 patients. The homogeneous pattern was the most frequent, followed by the reticular, cobblestone, and globular patterns. After dermabrasion, nearly half of the lesions (46%) became dermatoscopically asymmetric. Among all lesions, structureless areas, dotted vessels and erythema were the most frequent new dermoscopic structures. CONCLUSION: Trauma after dermabrasion may induce significant dermoscopic changes in melanocytic nevi. Although the global pattern did not change, most of the lesions became asymmetric, with the appearance or fading of dermoscopic structures and colors. A history of recent trauma should be investigated when evaluating pigmented lesions.
- 27 December 2021
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 48 (3) , 299-303
Dermoscopic Aspects of Traumatized Nevi After Dermabrasion
BACKGROUND: Melanocytic nevi submitted to trauma can undergo clinical, dermoscopic, and even histological changes, making it difficult to differentiate them from a melanoma. OBJECTIVE: The aim of this study is to evaluate the dermoscopic changes of traumatized nevi after dermabrasion. METHODS: Dermoscopic images of acquired melanocytic nevi were compared before and 4 weeks after half of their area had undergone dermabrasion. RESULTS: The sample consisted of 50 lesions from 15 patients. The homogeneous pattern was the most frequent, followed by the reticular, cobblestone, and globular patterns. After dermabrasion, nearly half of the lesions (46%) became dermatoscopically asymmetric. Among all lesions, structureless areas, dotted vessels and erythema were the most frequent new dermoscopic structures. CONCLUSION: Trauma after dermabrasion may induce significant dermoscopic changes in melanocytic nevi. Although the global pattern did not change, most of the lesions became asymmetric, with the appearance or fading of dermoscopic structures and colors. A history of recent trauma should be investigated when evaluating pigmented lesions.
- Open Access
- 1 November 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (6) , 735-745
Dermatoscopia das infestações e infecções cutâneas (entomodermatoscopia) – Parte I: dermatozoonoses e infecções bacterianas
- 1 November 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (6) , 735-745
Open AccessDermatoscopia das infestações e infecções cutâneas (entomodermatoscopia) – Parte I: dermatozoonoses e infecções bacterianas
- Open Access
- 1 November 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (6) , 746-758
Dermatoscopia das infestações e infecções cutâneas (entomodermatoscopia) – Parte II: infecções virais, fúngicas e outras
- 1 November 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (6) , 746-758
Open AccessDermatoscopia das infestações e infecções cutâneas (entomodermatoscopia) – Parte II: infecções virais, fúngicas e outras
- Open Access
- 5 October 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (6) , 735-745
Dermoscopy of skin infestations and infections (entomodermoscopy) – Part I: dermatozoonoses and bacterial infections
- 5 October 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (6) , 735-745
Open AccessDermoscopy of skin infestations and infections (entomodermoscopy) – Part I: dermatozoonoses and bacterial infections
- Open Access
- 5 October 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (6) , 746-758
Dermoscopy of skin infestations and infections (entomodermoscopy) – Part II: viral, fungal and other infections
- 5 October 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (6) , 746-758
Open AccessDermoscopy of skin infestations and infections (entomodermoscopy) – Part II: viral, fungal and other infections